A BILL to amend the Code of Virginia by adding sections numbered 32.1-127.1:06 and 38.2-3407.15:9, relating to genetic sequencing; organ transplants; use of foreign genetic sequencing or genetic sequencer operational and research software; foreign storage of genetic sequencing data; health insurance coverage for certain foreign organ transplants; civil penalty.
HB685 would add two new sections to the Code of Virginia addressing genetic sequencing privacy and health insurance coverage for certain organ transplants. First, it would prohibit medical care facilities from using genetic sequencers or related operational and research software produced in or by a “foreign adversary,” and would restrict storage or remote access to genetic sequencing data by foreign adversaries unless approved by the Commissioner. Covered facilities would have to certify compliance annually, and violations could trigger civil penalties of $10,000 per violation, with enforcement authority vested in the Commissioner of Health.
Second, the bill would prohibit health carriers from covering organ transplants performed in the People’s Republic of China, or in other countries later designated by the Commissioner as facilitating forced organ harvesting, and would also bar coverage for organs procured by sale or donation originating in those countries. Violations by carriers would carry a $100,000 civil penalty per violation. The bill also states that it may increase periods of imprisonment or juvenile commitment, triggering a minimum fiscal impact estimate.
HB685 would create new restrictions on hospitals, medical care facilities, and health insurance carriers, adding compliance, certification, investigation, and penalty provisions to Virginia law. It would expand state oversight of genomic data security and foreign technology use in medical genetics, while also giving the Commissioner authority to designate additional countries for organ-transplant coverage restrictions and to enforce civil penalties. The bill would affect medical facilities, data storage vendors, insurers, and patients seeking transplants abroad or through foreign-sourced organs.
The available context suggests the bill was introduced and referred to the House Committee on Health and Human Services, where it was left in committee with no recorded votes or transcript debate. Based on the text, the bill appears to be framed around national security, privacy, and human-rights concerns, especially regarding foreign control of genetic data and forced organ harvesting. Because there is no recorded committee discussion or vote history, there is no documented public sentiment in the provided materials beyond the bill’s stated policy goals.
The main points of contention likely center on the breadth and enforceability of the foreign-adversary restrictions, including whether facilities can realistically verify the origin of sequencing hardware and software without inspecting individual components. Another likely issue is the scope of the organ-transplant insurance ban, particularly the Commissioner’s authority to add countries and the impact on coverage decisions for patients who may seek transplants overseas. Potential concerns also include compliance costs for medical facilities and insurers, data-security obligations, and the bill’s civil penalties and possible criminal justice fiscal effects.